Compare XOMA & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XOMA | RFI |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.7M | 293.7M |
| IPO Year | N/A | N/A |
| Metric | XOMA | RFI |
|---|---|---|
| Price | $26.50 | $11.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $63.25 | N/A |
| AVG Volume (30 Days) | ★ 207.7K | 69.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $47,106,000.00 | N/A |
| Revenue This Year | $77.29 | N/A |
| Revenue Next Year | $34.91 | N/A |
| P/E Ratio | $34.07 | ★ N/A |
| Revenue Growth | ★ 118.02 | N/A |
| 52 Week Low | $18.35 | $9.62 |
| 52 Week High | $39.92 | $12.52 |
| Indicator | XOMA | RFI |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 45.67 |
| Support Level | $25.12 | $10.82 |
| Resistance Level | $27.08 | $11.17 |
| Average True Range (ATR) | 1.31 | 0.11 |
| MACD | 0.34 | 0.03 |
| Stochastic Oscillator | 46.56 | 57.14 |
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.